Masafumi Tsujimoto Selected Research

Masafumi Tsujimoto Research Topics

Disease

7	Neoplasms (Cancer) 02/2009 - 11/2002
6	Choriocarcinoma 04/2006 - 01/2002
3	Hypertension (High Blood Pressure) 09/2009 - 03/2006
2	Hypoxia (Hypoxemia) 11/2013 - 09/2009
2	Pre-Eclampsia (Preeclampsia) 11/2013 - 09/2009
2	Inflammation (Inflammations) 02/2011 - 09/2003
2	Breast Neoplasms (Breast Cancer) 08/2010 - 03/2005
2	Atherosclerosis 05/2010 - 07/2004
2	Infections 06/2009 - 09/2006
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 02/2009 - 11/2005
2	Carcinoma (Carcinomatosis) 04/2007 - 04/2003
2	Endometrial Neoplasms (Endometrial Cancer) 12/2003 - 08/2003
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Premature Obstetric Labor (Premature Labor) 11/2013
1	Ductal Carcinoma 08/2010
1	Bacterial Infections (Bacterial Infection) 05/2010
1	Hypersensitivity (Allergy) 05/2009
1	Cataract (Cataracts) 02/2009
1	Renovascular Hypertension (Goldblatt Syndrome) 09/2008
1	Sarcoma (Soft Tissue Sarcoma) 06/2006
1	Phototoxic Dermatitis (Phototoxicity) 11/2005
1	Trophoblastic Neoplasms (Trophoblastic Tumor) 12/2003
1	Placental Site Trophoblastic Tumor 12/2003
1	Ataxia with vitamin E deficiency 10/2003
1	Adenocarcinoma 04/2003
1	Vascular Remodeling 09/2002

Drug/Important Bio-Agent (IBA)

6	AminopeptidasesIBA 01/2018 - 12/2003
6	leucyl-cystinyl aminopeptidaseIBA 11/2013 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 08/2010 - 04/2003
4	Oxytocin (Pitocin)FDA LinkGeneric 11/2013 - 04/2003
4	Peptides (Polypeptides)IBA 09/2009 - 04/2003
3	Angiotensin IIIBA 11/2013 - 09/2008
3	Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA 11/2013 - 09/2008
3	EnzymesIBA 09/2008 - 04/2003
3	Leucyl Aminopeptidase (Peptidase S)IBA 03/2006 - 08/2003
3	Cystinyl AminopeptidaseIBA 03/2004 - 02/2003
2	Vasopressins (Vasopressin)IBA 11/2013 - 09/2009
2	CytokinesIBA 02/2011 - 02/2003
2	Y-Box-Binding Protein 1IBA 08/2010 - 03/2005
2	N- beta- alanyl- 5- S- glutathionyl- 3,4- dihydroxyphenylalanineIBA 02/2009 - 06/2006
2	Messenger RNA (mRNA)IBA 02/2009 - 11/2005
2	Complementary DNA (cDNA)IBA 12/2003 - 04/2003
1	Multifunctional EnzymesIBA 01/2018
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 11/2013
1	Hormones (Hormone)IBA 11/2013
1	Peptide Hormones (Polypeptide Hormones)IBA 11/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2011
1	Small Interfering RNA (siRNA)IBA 08/2010
1	Glycoproteins (Glycoprotein)IBA 05/2010
1	Antihypertensive Agents (Antihypertensives)IBA 09/2009
1	AnionsIBA 06/2009
1	Superoxides (Superoxide)IBA 06/2009
1	N-acetylcarnosineIBA 02/2009
1	catechol (pyrocatechol)IBA 02/2009
1	DiamideIBA 02/2009
1	Free RadicalsIBA 02/2009
1	Galactose (Galactopyranose)FDA LinkGeneric 02/2009
1	tempolIBA 02/2009
1	SaltsIBA 09/2008
1	Scavenger Receptors (Scavenger Receptor)IBA 09/2006
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2006
1	Leukemia Inhibitory FactorIBA 04/2006
1	hypericinIBA 11/2005
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2005
1	DNA (Deoxyribonucleic Acid)IBA 11/2005
1	Estrogen ReceptorsIBA 03/2005
1	Lipoproteins (Lipoprotein)IBA 07/2004
1	low density lipoprotein inhibitorIBA 07/2004
1	Insulin (Novolin)FDA Link 03/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2003
1	LipidsIBA 10/2003
1	alpha-Tocopherol FDA Link 10/2003
1	alpha-tocopherol transfer proteinIBA 10/2003
1	AntioxidantsIBA 10/2003
1	ColforsinIBA 09/2003
1	DecorinIBA 09/2003
1	Interleukin-1beta (Interleukin 1 beta)IBA 02/2003
1	beta-D-Galactoside alpha 2-6-SialyltransferaseIBA 11/2002
1	matrigelIBA 09/2002
1	Monoclonal AntibodiesIBA 09/2002

Therapy/Procedure

1	Therapeutics 08/2010
1	Lenses 02/2009
1	Aftercare (After-Treatment) 02/2009
1	Chemoradiotherapy 02/2009
1	Radiotherapy 02/2009
1	Photochemotherapy (Photodynamic Therapy) 11/2005
1	Adjuvant Chemotherapy 03/2005